Is GV.PA a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Genomic Vision SA (GV.PA) is (1.25) EUR. With the latest stock price at 0.00 EUR, the upside of Genomic Vision SA based on DCF is -69382.0%. This means that GV.PA is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.1% - 4.5% | 4.3% |
| Long-term Growth Rate | 3.0% - 3.9% | 3.4% |
| Fair Price | (4.23) - (0.74) | (1.25) |
| Upside | -235354.2% - -41327.9% | -69382.0% |